Navigation Links
American Society of Transplantation's Past President Testifies Before Congress at Forum on Organ Donation
Date:9/25/2007

WASHINGTON, Sept. 25 /PRNewswire-USNewswire/ -- American Society of Transplantation (AST) Past President Jeffrey S. Crippin, MD, testified before the U.S. House of Representatives' Information, Policy, Census and National Archives Subcommittee of the Oversight and Government Reform Committee today, urging the subcommittee to use public policy and technology to strengthen the nation's organ donor programs.

According to Dr. Crippin, over 97,000 individuals are awaiting a life-saving donor organ. Between January and June of this year, about 14,000 transplants were performed in the U.S. with 11,083 deceased-donor organs and 3,200 living-donor organs. With such a shortage of available organs, "protecting a patient's life-saving donor organ is critical," Dr. Crippin said. Optimal care is essential to ensure the long-term survival of an organ recipient.

For many patients, one of the greatest barriers at each stage of the organ transplantation process is the lack of insurance coverage, which can extend from the time the patient is placed on the waiting list until after the transplant. For many years, the federal government paid for the organ transplant but only for 36 months of immunosuppressive drug treatment. This policy resulted in patients losing the transplanted organ, returning to dialysis, or losing their lives.

Dr. Crippin asked the subcommittee to support the "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," bipartisan legislation (H.R. 3282) introduced by U.S. Rep. Dave Camp (R-MI) in August to cover gaps in Medicare coverage for immunosuppressive drugs.

According to Dr. Crippin, coverage for immunosuppressive drugs is just one of four initiatives that the AST supports to protect the scarce resource of a donor organ. The initiatives are:

-- Extension of coverage of immunosuppressive medications for the lifetime

of the transplanted organ.

-- Patient access to transplant centers.

-- Access to insurance coverage, especially for pediatric patients.

-- Development of programs for patient and professional education

regarding early treatment of diseases that lead to the need for organ

transplants.

Dr. Crippin applauded the efforts of Chairman William Lacy Clay (D-MO), Ranking Member Michael Turner (R-OH) and the subcommittee members to meet, discuss and examine how the nation's solid organ transplant system can be strengthened.

Dr. Crippin also acknowledged the role played by Chairman Clay, U.S. Reps. Camp, Jim Costa (D-CA) and Ileana Ros-Lehtinen (R-FL) in reviving the Congressional Organ and Tissue Caucus.

Dr. Crippin is the Immediate Past President of the AST and the Medical Director of the Liver Transplant Program at Barnes Jewish Hospital in St. Louis, Mo.

About AST

Founded in 1982, the American Society of Transplantation is dedicated to advancing the field of transplantation through the promotion of research, education, advocacy, and organ donation to improve patient care. The international society includes more than 2,700 transplant physicians, surgeons and allied health professionals. In 2007, the AST celebrates 25 years of promoting excellence in the field of transplantation. For information about AST, please visit http://www.a-s-t.org.

Contact: Beth Drost

215.884.6499


'/>"/>
SOURCE American Society of Transplantation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Abstain from sex- the latest mantra of American teens
2. Clintons new problem - Is the outgoing American president suffering from skin cancer?
3. American scientists alter gene makeup of babies
4. FDA attacks American Red Cross for blood violations
5. Poll Finds Many Americans Misinformed About Cancer
6. Poll Finds Many Americans Misinformed About Cancer
7. Hypertension Drug of Choice for African Americans
8. 38 million Americans including 14 million children left to combat hunger
9. Americans Consume Far Too Much Salt and Sodium
10. Americans Growing Out Of Shape
11. Rise in Stress among Americans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... ... Center is now offering various types of dental implants to restore lost teeth. Dental implants ... such as crowns, bridges, or dentures. An implant is placed directly into the jawbone where ... tooth. , Several types of dental implants are available, including: , ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for ... the hiring of Richard Robinson as chief operating officer (COO). In this role, ... a proven track record of simplifying business processes and developing growth strategies to ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... leakage is revolutionizing the way women look and feel about themselves and their ... of female sexual dysfunction and urinary leakage head on with a ground breaking ...
(Date:6/26/2017)... , ... June 26, 2017 , ... ... staff, and consumers are seeing lots of red these days. According to recent ... charges that result from medical coding errors(1). Some studies point to Electronic Health ...
(Date:6/26/2017)... ... June 26, 2017 , ... New patients with ... Angela Cotey, with or without a referral. Dr. Cotey is a trusted dentist who ... preferred tooth replacement option. , Patients with missing teeth in Fitchburg, WI, are encouraged ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: